IP Library Patent Application 16177596
Patent Application
App. No. 16/177,596

REMOTE ANALYTE MONITORING AND INSULIN DELIVERY SYSTEM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/177,596
Abstract

In one aspect, an analyte monitoring and insulin delivery system is provided. The system may include an analyte sensor configured to convey sensor data indicative of a measurement of one or more detectable properties based on an amount or concentration of an analyte. The system may include a transceiver configured to receive the sensor data and calculate an analyte level based on the sensor data. The system may include a display device configured to receive calculate an adjusted insulin delivery rate for an insulin pump and display the received analyte level and/or the adjusted insulin delivery rate. The system may include the insulin pump configured to increase, decrease or maintain a first insulin delivery rate based on the adjusted insulin delivery rate. The display device may further display icons corresponding to the system components and an operational status indicator for each icon.

Claims (63)

1 . An analyte monitoring and insulin delivery system comprising:

an analyte sensor including an analyte indicator that produces one or more detectable properties based on an amount or concentration of an analyte in proximity to the analyte indicator, wherein the analyte sensor is configured to convey sensor data indicative of a measurement of one or more of the detectable properties;

a transceiver configured to:

receive the sensor data conveyed from the analyte sensor,

calculate an analyte level using at least the received sensor data, and

convey the analyte level;

an insulin pump; and

a display device configured to:

receive the analyte level conveyed from the transceiver,

calculate, based at least on the received analyte level, an adjusted delivery rate for the insulin pump,

convey the adjusted delivery rate to the insulin pump,

display, via a user interface, a first display comprising the received analyte level and the adjusted delivery rate, and

display, via the user interface, a second display comprising: (i) a sensor icon and a sensor status indicator indicating an operational status of the analyte sensor, (ii) a transceiver icon and a transceiver status indicator indicating an operational status of the transceiver, and (iii) a pump icon and an insulin pump status indicator indicating an operational status of the insulin pump;

wherein the insulin pump is configured to:

deliver insulin at a first delivery rate,

receive the adjusted delivery rate conveyed by the display device, and

increase, decrease, or maintain the first delivery rate based on the received adjusted delivery rate.

2 . The analyte monitoring and insulin delivery system of claim 1 , further comprising:

an analyte meter configured to:

receive the analyte level conveyed from the transceiver, and

display the received analyte level;

wherein the second display further comprises a meter icon and a meter status indicator indicating an operational status of the analyte meter.

3 . The analyte monitoring and insulin delivery system of claim 1 , wherein the display device is further configured to compare the adjusted delivery rate with the first delivery rate; and

the first display further comprises a delivery rate indication of whether the adjusted delivery rate is an increase, a decrease, or a continuation of the first delivery rate.

4 . The analyte monitoring and insulin delivery system of claim 1 , wherein:

the display device is further configured to compare the received analyte level with one or more previously stored analyte levels; and

the first display further comprises an indication of whether the received analyte level is an increase, a decrease, or a continuation of the one or more previously stored analyte levels.

5 . The analyte monitoring and insulin delivery system of claim 1 , wherein the first display further comprises an indication that the received analyte level is below, within, or above a predetermined range of analyte levels.

6 . The analyte monitoring and insulin delivery system of claim 1 , wherein the first display further comprises a message bar configured to display one or more messages containing information regarding the analyte monitoring and insulin delivery system.

7 . The analyte monitoring and insulin delivery system of claim 1 , wherein the first display further comprises an analyte trend graph icon, the display device is further configured to display a third display in response to a user selection of the of the analyte trend graph icon, and the third display comprises an analyte trend graph showing an analyte level line that indicates a change in analyte level over a period of time.

8 . The analyte monitoring and insulin delivery system of claim 1 , wherein the first display further comprises an events panel comprising one or more event icons.

9 . The analyte monitoring and insulin delivery system of claim 1 , wherein the second display further comprises an autopilot icon and an autopilot status indicator indicating an operational status of automatic adjustment of insulin delivery.

10 . The analyte monitoring and insulin delivery system of claim 1 , wherein the sensor, transceiver, and insulin pump status indicators indicate an operational status with one of a normal sign, a warning sign, a failure sign, and a status unknown sign.

11 . The analyte monitoring and insulin delivery system of claim 1 , wherein the second display comprises a visual map of the analyte monitoring and insulin delivery system, and the visual map includes at least the sensor icon, the sensor status indicator, the transceiver icon, the transceiver status indicator, the pump icon, and the insulin pump status indicator.

12 . The analyte monitoring and insulin delivery system of claim 1 , wherein one or more of the sensor icon, the transceiver icon, and the pump icon of the second display are selectable, and the second device is further configured to, in response to a selection of one of the icons, provide additional information about the one of the analyte sensor, the transceiver, and the insulin pump to which the selected icon corresponds.

13 . An analyte monitoring and insulin delivery method comprising:

using a transceiver to receive sensor data from an analyte sensor, wherein the analyte sensor includes an analyte indicator that produces one or more detectable properties based on an amount or concentration of an analyte in proximity to the analyte indicator the analyte sensor is configured to convey the sensor data, and the sensor data is indicative of a measurement of one or more of the detectable properties;

using the transceiver to calculate an analyte level using at least the received sensor data;

using the transceiver to convey the analyte level;

using a display device to receive the analyte level conveyed from the transceiver;

using the display device to calculate, based at least on the received analyte level, an adjusted delivery rate for an insulin pump;

using the display device to convey the adjusted delivery rate to the insulin pump;

using the display device to display, via a user interface, a first display comprising the received analyte level and the adjusted delivery rate;

using the display device to display, via the user interface, a second display comprising: (i) a sensor icon and a sensor status indicator indicating an operational status of the analyte sensor, (ii) a transceiver icon and a transceiver status indicator indicating an operational status of the transceiver, and (iii) a pump icon and an insulin pump status indicator indicating an operational status of the insulin pump;

using the insulin pump to deliver insulin at a first delivery rate;

using the insulin pump to receive the adjusted delivery rate conveyed by the display device; and

using the insulin pump to increase, decrease, or maintain the first delivery rate based on the received adjusted delivery rate.

14 . The analyte monitoring and insulin delivery method of claim 13 , further comprising:

using an analyte meter to receive the analyte level conveyed from the transceiver; and

using the analyte meter display the received analyte level,

wherein the second display further comprises a meter icon and a meter status indicator indicating an operational status of the analyte meter.

15 . The analyte monitoring and insulin delivery method of claim 13 , further comprising using the display device to compare the adjusted delivery rate with the first delivery rate;

wherein the first display further comprises a delivery rate indication of whether the adjusted delivery rate is an increase, a decrease, or a continuation of the first delivery rate.

16 . The analyte monitoring and insulin delivery method of claim 13 , further comprising using the display device to compare the received analyte level with one or more previously stored analyte levels;

wherein the first display further comprises an indication of whether the received analyte level is an increase, a decrease or a continuation of the one or more previously stored analyte levels.

17 . The analyte monitoring and insulin delivery method of claim 13 , wherein the first display further comprises an indication that the received analyte level is below, within, or above a predetermined range of analyte levels.

18 . The analyte monitoring and insulin delivery method of claim 13 , wherein the first display further comprises a message bar configured to display one or more messages containing information regarding the analyte monitoring and insulin delivery system.

19 . The analyte monitoring and insulin delivery method of claim 13 , wherein the first display further comprises an analyte trend graph icon, the method further comprises displaying a third display in response to a user selection of the of the analyte trend graph icon, and the third display comprises an analyte trend graph showing an analyte level line that indicates a change in analyte level over a period of time.

20 . The analyte monitoring and insulin delivery method of claim 13 , wherein the first display further comprises an events panel comprising one or more event icons.

21 . The analyte monitoring and insulin delivery method of claim 13 , wherein the second display further comprises an autopilot icon and an autopilot status indicator indicating an operational status of automatic adjustment of insulin delivery.

22 . The analyte monitoring and insulin delivery method of claim 13 , wherein the sensor, transceiver, and insulin pump status indicators indicate an operational status with one of a normal sign, a warning sign, a failure sign, and a status unknown sign.

23 . The analyte monitoring and insulin delivery method of claim 13 , wherein the second display comprises a visual map of an analyte monitoring and insulin delivery system including at least the analyte sensor, transceiver, and insulin pump, and the visual map includes at least the sensor icon, the sensor status indicator, the transceiver icon, the transceiver status indicator, the pump icon, and the insulin pump status indicator.

24 . The analyte monitoring and insulin delivery method of claim 13 , wherein one or more of the sensor icon, the transceiver icon, and the pump icon of the second display are selectable, and the method further comprises, in response to a selection of one of the icons, providing additional information about the one of the analyte sensor, the transceiver, and the insulin pump to which the selected icon corresponds.

Assignments (9)
SECURITY INTEREST Recorded Sep 11, 2023
From: SENSEONICS, INCORPORATED
To: HERCULES CAPITAL, INC.
Reel/Frame 064866/0963 →
RELEASE OF SECURITY INTEREST Recorded Sep 7, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
To: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
Reel/Frame 064834/0962 →
RELEASE OF SECURITY INTEREST Recorded Apr 14, 2023
From: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
To: SENSEONICS HOLDINGS, INC.; SENSEONICS, INCORPORATED
Reel/Frame 063338/0890 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 14, 2020
From: SENSEONICS, INCORPORATED
To: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
Reel/Frame 053496/0292 →
RELEASE OF SECURITY INTEREST IN PATENTS AND TRADEMARKS Recorded Aug 14, 2020
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, COLLATERAL AGENT
To: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
Reel/Frame 053498/0275 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT - FIRST LIEN Recorded Apr 24, 2020
From: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 052492/0109 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT -SECOND LIEN Recorded Apr 24, 2020
From: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 052490/0160 →
RELEASE OF SECURITY INTEREST Recorded Mar 23, 2020
From: SOLAR CAPITAL LTD., AS AGENT
To: SENSEONICS, INCORPORATED
Reel/Frame 052207/0242 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 1, 2019
From: SENSEONICS, INCORPORATED
To: SOLAR CAPITAL LTD., AS AGENT
Reel/Frame 049926/0827 →